PCM
NTUS

Peregrine Capital Management’s Natus Medical Inc NTUS Stock Holding History

Peregrine Capital Management’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-235,767
Closed -$8.4M – 326
2018
Q3 		$8.4M Sell
235,767
-3,561
-1% -$126K 0.2% 160
2018
Q2 		$8.26M Sell
239,328
-55,232
-19% -$1.94M 0.21% 154
2018
Q1 		$9.91M Buy
+294,560
New +$9.32M 0.24% 148

Other funds holding NTUS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

Peregrine Capital Management's NTUS Position: Q4 2018 in Review

Peregrine Capital Management sold out of Natus Medical Inc (NTUS) in Q4 2018, closing a stake of 235,767 shares — an estimated $8.4M sold.

Peregrine Capital Management first reported a position in NTUS in Q1 2018 and held it in 3 quarters. The position peaked at $9.91M in Q1 2018. 174 funds tracked by Wall St. Rank hold NTUS as of Q4 2018.

  • Peregrine Capital Management reported no remaining Natus Medical Inc position as of Q4 2018 after selling out during the quarter.
  • Peregrine Capital Management sold 235,767 Natus Medical Inc shares in Q4 2018, an estimated $8.4M.
  • Peregrine Capital Management first reported a position in Natus Medical Inc in Q1 2018 and held it in 3 quarters.
  • Peregrine Capital Management's Natus Medical Inc position peaked at $9.91M in Q1 2018.
  • 174 funds tracked by Wall St. Rank held Natus Medical Inc as of Q4 2018.

Based on Peregrine Capital Management's 13F filing for Q4 2018, filed 17 Jan 2019.